The independent source for health policy research, polling, and news.
1,081 - 1,100 of 3,992 Results
“What happens in Texas doesn't stay in Texas,” warns an abortion rights advocate bracing for a district judge’s ruling on whether the abortion pill mifepristone was properly authorized by the FDA. His decision could force the medication off the U.S. market.
CMS advanced two proposed changes that could affect Medicare Advantage plans. One would allow the government to recover past overpayments. As a result, it could reduce those insurers’ profits, leading them to increase enrollees' out-of-pocket costs or reduce benefits. But it's inaccurate to characterize the changes as "cuts."
Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relatively small pools of patients.
The Senate’s top health committee focused on the worsening health care workforce shortage during its first hearing Thursday, with Sen. Bernie Sanders, its new chair, boldly promising bipartisan solutions.
Hundreds of physicians came to Washington this week to lobby Congress about their “recovery plan” for physicians, which includes a Medicare pay boost and an end to some frustrating insurance company requirements.
The billionaire entrepreneur and NBA team owner is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.
At many U.S. hospitals, children and teens are stuck in the emergency department for days or weeks because psychiatric beds are full. Massachusetts is trying a simple, promising solution.
State Sen. María Elena Durazo and Service Employees International Union-United Healthcare Workers West want to give health facility support staffers a raise. Hospitals, nursing homes, and dialysis clinics are expected to resist.
As a money-saving strategy, emergency rooms are turning to nurse practitioners, physician assistants, and other staffers who earn far less than physicians.
The bill, modeled on laws in North Dakota and Wyoming, is opposed by doctors who say it would let physician assistants practice outside the scope of their training.
A private equity firm bought a birth center and then shut it down. The community brought it back as a nonprofit.
The nation’s largest Medicaid insurer denies wrongdoing after the California attorney general’s office investigated it for inflating prescription drug costs.
As he takes the reins of the Senate Health, Education, Labor & Pensions Committee, the independent from Vermont and implacable champion of “Medicare for All” maps out his strategy for negotiating with Republicans — and Big Pharma.
Pharmacy closures by two of the biggest home infusion companies point to grave shortages and dangers for patients who require IV nutrition to survive.
The Vaccines for Children program, which buys more than half the pediatric vaccines in the U.S., may not cover the RSV shot for babies because it’s not technically a vaccine.
States are trying to reach millions of Medicaid enrollees to make sure those still eligible remain covered and help others find new health insurance.
As the federal government debates whether to require higher staffing levels at nursing homes, financial records show owners routinely push profits to sister companies while residents are neglected. “A dog would get better care than he did,” one resident’s wife said.
Private equity groups are cashing in on rising rates of alcohol and drug addiction in the U.S. But they aren’t necessarily investing in centers with the best treatment standards, and they often cut extra services.
In a surprise decision, U.S. officials yield to insurance industry demands — at least for now.
Supporters of a proposed law say it would fill a health provider gap in rural areas, while doctors worry it will give pharmacists power outside the scope of their education.
© 2026 KFF